Perros Ioannis, Sokhal Balamrit Singh, Swift Christopher, Kitchen Mark, Mallen Christian, Somani Bhaskar
School of Medicine, Keele University, Keele, UK.
Royal Stoke University Hospital, University Hospital of North Midlands, Stoke-On-Trent, UK.
World J Urol. 2025 Sep 16;43(1):557. doi: 10.1007/s00345-025-05920-x.
To evaluate the effectiveness of Sterile water injections (SWIs) for acute pain relief in renal colic.
This study was conducted in accordance with the Preferred Reporting items for Systematic Reviews and Meta-Analyses. MEDLINE, CINAHL, Web of Science and Cochrane were searched to identify randomised controlled trials (RCTs) comparing SWIs with placebo or other analgesics in renal colic patients. Data were pooled and analysed using random effects modelling with 95% confidence intervals (CIs).
Six RCTs including 1322 renal colic patients were included, with 466 (35.2%) receiving SWIs. Patients receiving SWIs had comparable demographics and presenting features to the control groups, with control medications ranging from placebos, non-steroidal anti-inflammatories, and opioids. Self-reported pain scores at 30 min following intervention were lower in SWI than placebo (MD = - 4.63, 95% CI: - 5.16, - 4.10, P < 0.001) and other analgesics (MD = - 0.36, 95% CI: - 0.52, - 0.21, P < 0.001). The use of rescue analgesia was lower in those receiving SWIs compared to placebo (OR = 0.24, 95% CI: 0.10, 0.59, P = 0.002) and other analgesics (OR = 0.46, 95% CI: 0.29, 0.74, P = 0.001). No significant side effects were attributed to SWI use.
SWIs demonstrated superior pain relief and reduced rescue analgesia requirements, compared to placebo and standard treatment, offering a promising alternative for patients where traditional options are unsuitable.
评估无菌水注射(SWIs)缓解肾绞痛急性疼痛的有效性。
本研究按照系统评价和Meta分析的首选报告项目进行。检索MEDLINE、CINAHL、科学网和Cochrane数据库,以确定比较SWIs与安慰剂或其他镇痛药治疗肾绞痛患者的随机对照试验(RCTs)。使用随机效应模型和95%置信区间(CIs)对数据进行汇总和分析。
纳入6项RCTs,共1322例肾绞痛患者,其中466例(35.2%)接受SWIs治疗。接受SWIs治疗的患者与对照组在人口统计学和临床表现特征方面具有可比性,对照药物包括安慰剂、非甾体抗炎药和阿片类药物。干预后30分钟时,SWIs组的自我报告疼痛评分低于安慰剂组(MD=-4.63,95%CI:-5.16,-4.10,P<0.001)和其他镇痛药组(MD=-0.36,95%CI:-0.52,-0.21,P<0.001)。与安慰剂组(OR=0.24,95%CI:0.10,0.59,P=0.002)和其他镇痛药组(OR=0.46,95%CI:0.29,0.74,P=0.001)相比,接受SWIs治疗的患者使用解救镇痛药的情况较少。未发现SWIs使用有明显副作用。
与安慰剂和标准治疗相比,SWIs在缓解疼痛方面表现更优,且减少了解救镇痛药的使用需求,为传统治疗方法不适用的患者提供了一个有前景的替代选择。